NFE2L2 and non-small cell lung carcinoma: In addition, NR0B1, an orphan nuclear receptor expressed in KEAP1-mutant NSCLC, has been identified as potential druggable target [144], while tumours with overactivation of NRF2 show selective vulnerability to inhibitors of respiratory complex I [145].